Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy

Journal of Pathology

Volumn 187, Issue 3, 1999, Pages 345-350

  Romagnani, Paola ^c   Pupilli, Cinzia ^a   Lasagni, Laura ^c   Baccari, Maria C ^c   Bellini, Francesca ^c   Amorosi, Andrea ^c   Bertoni, Elisabetta ^b   Serio, Mario ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Transplantation Centre   (Italy)

^c NONE

Author keywords

Allograft nephropathy; Chronic rejection; iNOS; Kidney; Mesangial cell; Vascular smooth muscle cell

Indexed keywords

ALPHA ACTIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VASCULAR SMOOTH MUSCLE;

ADULT; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; RNA, MESSENGER;

EID: 0032925212     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199902)187:3<345::AID-PATH239>3.0.CO;2-Z     Document Type: Article

References (22)

1. Riesten CJ. In: Terasaki P, ed. Clinical Transplantation. Los Angeles: University of California, Los Angeles, Tissue Typing Laboratory, 1991; 225.
2. Dennis MJS, Foster MC, Ryan JJ, Burden RP, Morgan AG, Blarney RW. The increasing importance of chronic rejection as a cause of renal allograft failure. Transplant Int 1989; 2: 214-217.
3. Lemström K, Koskinen P, Leyry P. Molecular mechanisms of chronic renal allograft rejection. Kidney Int 1995; 48 (Suppl 52): S2-S10.
4. Cook HT, Cattell V. Role of nitric oxide in immune-mediated diseases. Clin Sci 1996; 91: 375-384.
5. Akyürek LM, Fellström BC, Yan Z, Hansson GK, Funa K, Larsson E. Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. Am J Pathol 1996; 149: 1981-1990.
6. Russell ME, Wallace AF, Wyner LR, Newell JB, Karnovsky MJ. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation 1995; 92: 457-464.
7. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728.
8. Cattell V, Smith J, Jansen A, Riveros-Moreno V, Moncada S. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat. Transplantation 1994; 58: 1399-1402
9. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181: 63-70.
10. Solez K, Axelsen RA, Hallgrimur B, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
11. Pendino KJ, Meidhof TM, Heck DE, Laskin JD, Laskin DL. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. Am J Respir Cell Mol Biol 1995; 13: 125-132.
12. Romagnani P, Annunziato F, Manetti R, et al. High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus. Blood 1998; 91: 3323-3332.
13. Pupilli C, Romagnani P, Lasagni L, et al. Localization of endothelin-converting enzyme-1 in human kidney. Am J Physiol 1997; 273: F749-F756.
14. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993; 90: 3491-3495.
15. Kashem A, Masayukki E, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible-NOS in human glomerulonephrites: the possible source is infiltrating monocytes/macrophages. Kidney Int 1996; 50: 392-399.
16. Nadeau KC, Azuma H, Tilney NL. Seqential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 1995; 92: 8729-8733.
17. Hansson GK, Geng Y, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 1994; 180: 733-738.
18. Marumo T, Nakaki T, Hishikawa K, Suzuki H, Kato R, Saruta T. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension 1995; 25 (Part 2): 764-768.
19. Muhl H, Kunz D, Rob P, Pheilschifter J. Cyclosporin derivatives inhibit interleukin-1 beta induction of iNOS in renal mesangial cells. Eur J Pharmacol 1993; 249: 95-100.
20. Shears LL II, Kawaharada N, Tzeng E, et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 1997; 100: 2035-2042.
21. Craven PA, Studer RK, Felder J, Phillips S, DeRubertis F. Nitric oxide inhibition of transforming growth factor-β and collagen synthesis in mesangial cells. Diabetes 1997; 46: 671-681.
22. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.